🇺🇸 YKP3089 in United States

YKP3089 (YKP3089) regulatory status in United States.

Marketing authorisations

FDA

  • Application: ANDA219403
  • Marketing authorisation holder: ZENARA PHARMA PRIVATE LTD
  • Local brand name: CENOBAMATE
  • Indication: TABLET
  • Status: approved

Read official source →

FDA

  • Application: ANDA219473
  • Marketing authorisation holder: AUROBINDO PHARMA LIMITED
  • Local brand name: CENOBAMATE
  • Indication: TABLET
  • Status: approved

Read official source →

YKP3089 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is YKP3089 approved in United States?

Yes. FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for YKP3089 in United States?

ZENARA PHARMA PRIVATE LTD holds the US marketing authorisation.